We further compared the BimBH3 BaxΔC26 and the BidBH3 BaxΔC21 (PDB code 4DB2) structures to identify peptide protein interactions specific to either complex.
These interactions appeared to either reinforce already held perceptions that back pain was inevitable, and/or limit motivation to seek further pain care in the future, as shown in the following participant narratives.
A number of non-HIV related medications can be affected by, or directly affect, HIV medications through drug-drug interactions, leading to either significant toxicity or decreased efficacy of the target medications.
The drivers of pathogen emergence change the overall pattern of the pathogen host environment interactions leading to either (i) a pathogen showing up in a novel host; (ii) a mutant pathogen with novel traits causing more frequent or more severe disease while remaining in the same host; or (iii) an invasion process involving a novel geographic area.
Although interaction between NF- κB and ER α was reported about 8 years ago (Stein and Yang, 1995), how that interaction leads to either transactivation or transrepression is not known.
These interactions were proposed to either aid metal transfer or alter intramolecular interactions.
It will also be important to study the directionality of interactions, i.e., those that are pro-pathogen interactions as opposed to pro-host interactions[ 3], or even bystander interactions, incidental interactions of little consequence to either virus or host.
We also found that the presence of electron Coulomb interactions can lead to either reduction or enhancement of ZT, depending on whether the Fermi level is below or above the QD level.
Moreover, as atypical antipsychotics are extensively metabolised by cytochrome P-450, the potential for drug interactions increases, leading to either toxic or subtherapeutic levels [ 3].
Such interactions might serve to either titrate out factors that block abnormal proliferation (e.g., Rb, below), or upset a critical stoichiometric balance among Mcm subunits within the cell to increase nonproductive Mcm subassemblies at the expense of active hexamers.
